• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 54-68 of 314 results

Label

Document EPCLUSA, 208341, Label (Orange Book Jun. 10, 2021)

cite Cite Document
Analyze

2003 Exhibit: FDA Approves Game Changer Hepatitis C Drug Sofosbuvir

Document IPR2018-00122, No. 2003-17 Exhibit - FDA Approves Game Changer Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2017 Exhibit: Pro Nucleotides Recent Advances in the Design of Efficient Tools for ...

Document IPR2018-00122, No. 2017-29 Exhibit - Pro Nucleotides Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Feb. 28, 201...

cite Cite Document
Analyze

2004 Exhibit: HARVONI label

Document IPR2018-00122, No. 2004-18 Exhibit - HARVONI label (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2018 Exhibit: Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficien...

Document IPR2018-00122, No. 2018-30 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2 C Methylcytidine (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2012 Exhibit: FDA Approves Gileads Hepatitis C Drug

Document IPR2018-00122, No. 2012-26 Exhibit - FDA Approves Gileads Hepatitis C Drug (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2002 Exhibit: Curing Chronic Hepatitis C The Arc of a Medical Triumph

Document IPR2018-00122, No. 2002-16 Exhibit - Curing Chronic Hepatitis C The Arc of a Medical Triumph (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2007 Exhibit: Americas Overspend How the Pharmaceutical Patent Problem is Fue...

Document IPR2018-00122, No. 2007-21 Exhibit - Americas Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2008 Exhibit: I MAK Our People

Document IPR2018-00122, No. 2008-22 Exhibit - I MAK Our People (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2001 Exhibit: Nucleoside Analog Inhibitors of Hepatitis C Virus Replication

Document IPR2018-00122, No. 2001-15 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2015 Exhibit: Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ Cmethyluridine Nucleotide Prodru...

Document IPR2018-00122, No. 2015-27 Exhibit - Discovery of a ¿¿ D 2¿¿¿ Deoxy 2¿¿¿ ¿¿ Cmethyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2018 Exhibit: Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficien...

Document IPR2018-00122, No. 2018-30 Exhibit - Synthesis and Pharmacokinetics of Valopicitabine NM283, an Efficient Prodrug of the Potent Anti HCV Agent 2¿¿¿ C Methylcytidine (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2016 Exhibit: Review Article Investigational Agents for Chronic Hepatitis C

Document IPR2018-00122, No. 2016-28 Exhibit - Review Article Investigational Agents for Chronic Hepatitis C (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2003 Exhibit: FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir

Document IPR2018-00122, No. 2003-17 Exhibit - FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze

2006 Exhibit: Clofarabine From Design to Approval

Document IPR2018-00122, No. 2006-20 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Feb. 28, 2018)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 ... >>